Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study of teicoplanin therapy in critically ill children

Trial Profile

Study of teicoplanin therapy in critically ill children

Phase of Trial: Phase IV

Latest Information Update: 04 May 2018

At a glance

  • Drugs Teicoplanin (Primary)
  • Indications Bacterial infections; Gram-positive infections
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 04 May 2018 New trial record
    • 24 Apr 2018 Results evaluating PK/PD targets presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top